-

340B: AHF Blasts J&J’s Illegal Rebate Plan, Urges Senate to Act

HHS calls Johnson & Johnson’s plan to switch to a rebate plan from upfront drug price discounts ‘inconsistent’ with federal law

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) condemns the illegal scheme by Johnson & Johnson to stop providing required 340B discounts at time of sale to safety net covered entities, and instead provide rebates if and when J & J deigns to, which will shortchange and ultimately stiff program participants. J & J’s change means the drug maker may or may not reimburse providers at a later date, making every 340B-claim subject to dispute and protracted payment. The multibillion-dollar pharmaceutical giant is violating the law by unilaterally rewriting its 340B program obligations.

Ploys meant to deny 340B savings to their intended recipients are already too familiar to nonprofit healthcare providers. Johnson & Johnson is one of over 35 drug companies that have instituted contract pharmacy restrictions since the beginning of 2020. According to the drug maker, the new proposal will only affect disproportionate share hospitals, but it will be only a matter of time before they will try to extend to all 340B covered entities.

The Health Resources & Services Administration has said the proposed rebate model is inconsistent with the law. The 340B statute is clear – drug manufacturers must provide upfront discounts at or below the 340B ceiling price.

This rebate scam further confirms that PhRMA is not a good faith actor in efforts to change the 340B program. Pharmaceutical industry calls for 340B “reform” amount to little more than efforts to shrink the program and increase their profits.

Currently, an effort to “reform” the 340B program, called the SUSTAIN Act, is being drafted by six Senators.

“The Senators working on the SUSTAIN Act should figure in PhRMA’s bad faith when making their final draft of the bill, revisit PhRMA-friendly provisions already in their draft, and include language expressly outlawing this behavior,” said Tom Myers, General Counsel and Chief of Public Affairs for AHF.

AIDS Healthcare Foundation (AHF), the largest global HIV and AIDS organization, provides medical care and/or services to more that 2 million individuals in 47 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website, find us on Facebook, follow us on IG and Twitter, or subscribe to our “AHFter Hours” podcast.

Contacts

MEDIA CONTACT:
Ged Kenslea, AHF Communications +1.323.791.5526 mobile ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
340B: AHF Blasts J&J’s Illegal Rebate Plan, Urges Senate to Act
Release Versions

Contacts

MEDIA CONTACT:
Ged Kenslea, AHF Communications +1.323.791.5526 mobile ged.kenslea@ahf.org

More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom